Endurant Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,401	Closed	-$572K	–	62
2022 Q4	$572K	Buy	+16,401	New	+$572K	0.23%	43